A global pharmaceutical company, which produces pharmaceutical ingredients and intermediates, finished dosage forms and biotechnology products and markets them globally. It conducts research in the areas of cancer, diabetes, cardiovascular disease etc.


Updates from The Motley Fool

Latest updates on Dr. Reddy's Laboratories from Fool.com.  The Fool has written over 100 articles on Dr. Reddy's Laboratories.
The 20 Fastest Growers in Pharma

Why are investors willing to pay only 10 times earnings for some stocks, but 20, 50, even 100 tim...



Stock Performance

View Interactive RDY Charts
Sponsored by

Key Data Points

Primary metrics and data points about Dr. Reddy's Laboratories.
Current Price: $46.69
Prev Close: $46.69
Open: $46.20
Bid: $41.00
Ask: $50.79
Day's Range: $46.02 - $46.69
52wk Range: $40.68 - $54.73
Volume: 307,281
Avg Vol 346,387
Market Cap: $8B
P/E (ttm): 26.14
EPS (ttm): $1.77
Div & Yield: $0.31 (0.6%)

Company Rating

What our community thinks about Dr. Reddy's Laboratories.
CAPS Rating 4 out of 5
 
448 Outperform
26 Underperform
CAPS All Stars
 
75 Outperform
6 Underperform

How do you think Dr. Reddy's Laboratories will perform against the market?



You pick for Dr. Reddy's Laboratories is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Dr. Reddy's Laboratories.

A global pharmaceutical company, which produces pharmaceutical ingredients and intermediates, finished dosage forms and biotechnology products and markets them globally. It conducts research in the areas of cancer, diabetes, cardiovascular disease etc.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers